Beta Bionics Reports Q2 2026 Financial Results

What Happened

• Beta Bionics, Inc. announced its financial results for the second quarter ended June 30, 2026 and filed a Form 8-K on July 29, 2026 to disclose the earnings press release. The press release is attached to the filing as Exhibit 99.1. The report was signed by Sean Saint, President and Chief Executive Officer.

Key Details

• Filing date: July 29, 2026.
• Reporting period: quarter ended June 30, 2026.
• Press release attached as Exhibit 99.1 to the Form 8-K.
• Cover Page Interactive Data File (Inline XBRL) included (Exhibit 104); signature by Sean Saint.

Why It Matters

• This 8-K announces the company’s latest quarterly results—important for investors tracking Beta Bionics’ earnings, revenue, cash position, and guidance. The Form 8-K itself references the press release for the specific financial figures and commentary. Retail investors should review the attached press release and any accompanying public filings or investor materials for the detailed numbers and management commentary before making investment decisions.